Evidence map›Paper›PMID 34943088›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles.

Mariia R Mollaeva, Elena Nikolskaya, Veronika Beganovskaya, Maria Sokol, Margarita Chirkina, Sergey Obydennyi, Dmitry Belykh, Olga Startseva, Murad D Mollaev, Nikita Yabbarov

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe.International journal of molecular sciences · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Mariia R MollaevaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Elena NikolskayaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-1931-3117
Veronika BeganovskayaJSC Russian Research Center for Molecular Diagnostics and Therapy, 117149 Moscow, Russia.
Maria SokolN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Margarita ChirkinaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Sergey ObydennyiCenter for Theoretical Problems of Physicochemical Pharmacology, 119334 Moscow, Russia.ORCID 0000-0002-2930-8768
Dmitry BelykhInstitute of Chemistry of Komi Scientific Centre of the Ural Branch of Russian Academy of Sciences, 167982 Syktyvkar, Russia.ORCID 0000-0001-8553-5140
Olga StartsevaPitirim Sorokin Syktyvkar State University, 167001 Syktyvkar, Russia.ORCID 0000-0002-4411-585X
Murad D MollaevDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
Nikita YabbarovN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Russian Research Center for Molecular Diagnostics and Therapy · RUCenter for Theoretical Problems of Physicochemical Pharmacology · RUD. Mendeleyev University of Chemical Technology of Russia · RUDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology · RUInstitute of Biology of Komi Scientific Centre · RUSyktyvkar State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheophorbide a 17-diethylene glycol ester (XL-8), is a promising high-active derivative of known photosensitizer chlorin e6 used in photodynamic therapy. However, high lipophilicity and poor tumor accumulation limit XL-8 therapeutic application. We developed a novel XL-8 loaded with poly(D,L-lactide-co-glycolide) nanoparticles using the single emulsion-solvent evaporation method. The nanoparticles possessed high XL-8 loading content (4.6%) and encapsulation efficiency (87.7%) and a small size (182 ± 19 nm), and negative surface charge (-22.2 ± 3.8 mV) contributed to a specific intracellular accumulation. Sustained biphasic XL-8 release from nanoparticles enhanced the photosensitizer photostability upon irradiation that could potentially reduce the quantity of the drug applied. Additionally, the encapsulation of XL-8 in the polymer matrix preserved phototoxic activity of the payload. The nanoparticles displayed enhanced cellular internalization. Flow cytometry and confocal laser-scanning microscopy studies revealed rapid XL-8 loaded nanoparticles distribution throughout the cell and initiation of DNA damage, glutathione depletion, and lipid peroxidation via reactive oxygen species formation. The novel nanoformulated XL-8 simultaneously revealed a significant phototoxicity accompanied with enhanced photostability, in contrast with traditional photosensitizers, and demonstrated a great potential for further in vivo studies.

Indexed as

cell deathcellular uptakenanoparticlesoxidative stressphotodynamic therapyphotosensitizerPLGAreactive oxygen species

Identifiers

PMID34943088
PMCPMC8750000
OpenAlexW4200318040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.